A bioceramic surface bioactive coating and preparation method thereof

A bioactive coating is applied to bioceramics through a series of chemical reactions, forming a stable bond at the inorganic-organic interface, enabling bioceramics to dynamically respond to complex microenvironments and provide sustained drug release, enhancing their biostability and responsiveness.

CN116813381BActive Publication Date: 2024-12-03化学与精细化工广东省实验室潮州分中心 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310801215.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-07-03
Publication Date
2024-12-03
Estimated Expiration
2043-07-03

AI Technical Summary

Technical Problem

Bioceramics lack the stability and flexibility to respond to the complex causes of biological microenvironments, and traditional methods fail to effectively integrate bioactive ingredients, especially in high-temperature processing, making them unsuitable for personalized and customizable applications in complex structures.

Method used

A method for preparing a bioactive coating on a bioceramic surface, which involves suspending the bioceramic in a silane coupling agent solution, followed by a series of reactions, including immersing it in a reaction container, and then performing a series of chemical reactions to form a stable bond at the inorganic-organic interface, thereby forming an active amino site, followed by grafting phenylboronic acid molecules and double-bond modified polymers to create a boron-nitrogen coordination compound.

Benefits of technology

The method enhances the biostability and responsiveness of bioceramics, allowing them to dynamically regulate pathological microenvironments and provide sustained drug release, suitable for complex structures and personalized customization.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116813381B_ABST
    Figure CN116813381B_ABST
Patent Text Reader

Abstract

The invention discloses a method for preparing a bioceramic surface bioactive coating, wherein the bioceramic surface is modified and grafted with phenylboronic acid or N,N-bis(2-hydroxyethyl) groups, and further reacted with a double-bond modified polymer aqueous solution containing corresponding phenylboronic acid or N,N-bis(2-hydroxyethyl) active groups according to the principle of boron-nitrogen coordination, and a method of light cross-linking and curing is combined to construct a bioceramic surface bioactive coating. The bioactive coating constructed by the invention effectively improves the bioactivity of the bioceramic, and at the same time, solves the problem of poor biostability of the boron-nitrogen coordination compound by means of double-bond cross-linking enhancement, so that the invented bioactive coating has long-term biostability, microenvironment responsiveness and the ability of long-term sustained release of multiple drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of ceramic surface modification, and in particular relates to a bioceramic surface bioactive coating and a preparation method thereof. Background Art

[0002] Bioceramics have been widely used in the field of bone implants due to their good biocompatibility, but their biological activity is limited. Ceramic surface coating technology can effectively expand the application field of bioceramics and improve their use effect.

[0003] Due to the complex causes of bone defects, the biological microenvironment of certain defect sites has high requirements for bone implants, and traditional bioceramics cannot effectively meet the application requirements. Since bioceramics require high-temperature molding, it is impossible to add bioactive ingredients in situ. Therefore, introducing a multi-responsive borate-double-bond bioactive coating on the surface of bioceramics through ceramic surface modification technology, responding to and improving the special microenvironment of the defect through intrinsic regulation or drug delivery, is a reliable means to solve this problem. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a bioceramic surface bioactive coating and a preparation method thereof that solves the problems of stability of the bioceramic surface coating and mild and efficient loading of active ingredients. Its advancement and innovation lie in the development of high-stability surface post-treatment technology that can dynamically regulate the pathological microenvironment, providing a reliable solution for achieving field response and drug synergistic treatment.

[0005] The technical solution of the present invention to solve the above technical problems is:

[0006] A method for preparing a bioactive coating on a bioceramic surface comprises the following steps:

[0007] S1, suspending the prepared bioceramic body in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction, reacting at room temperature for 0.25 to 24 hours, to obtain an amino-modified bioceramic;

[0008] S2, immersing the amino-modified bioceramic in a solution of phenylboronic acid molecules containing carboxyl groups or N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups, wherein the solute of the solution is 1-50wt% by mass, and then performing a catalytic reaction under an EDC / DMAP system for 0.25-24h to obtain phenylboronic acid-modified bioceramic or N,N-bis(2-hydroxyethyl)-modified bioceramic;

[0009] S3, immersing the phenylboric acid modified bioceramic in an aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers or immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing double bonds and phenylboric acid modified polymers, wherein the solute of the solution is 1-50wt% by mass, and performing an oscillation reaction for 0.25-24h to obtain a boron-nitrogen internal coordination coating, and then after centrifugation, the boron-nitrogen internal coordination coating is subjected to a photopolymerization reaction for 10-1200s to induce double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0010] Specifically, the double bond and N,N-bis(2-hydroxyethyl) modified polymer in step S3 are obtained by amidation reaction of any one of N,N-bis(2-hydroxyethyl)ethylenediamine, N,N-bis(2-hydroxyethyl)-1,3-diaminopropane, N,N-bis(2-hydroxyethyl)-p-phenylenediamine with double bond modified chondroitin sulfate, double bond modified hyaluronic acid, double bond modified gelatin, double bond modified sodium alginate, double bond modified polyglutamic acid, double bond modified carboxymethyl cellulose, double bond modified polymethacrylic acid; or are obtained by amidation or esterification reaction of any one of N,N-bis(2-hydroxyethyl)aminoacetic acid, N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, N,N-bis(2-hydroxyethyl)-4-aminobutyric acid with double bond modified chitosan, double bond modified gelatin, double bond modified polyethylene glycol, double bond modified polyacrylamide.

[0011] Specifically, the double bond and phenylboronic acid modified polymer in step S3 is obtained by amidation reaction of any one of 4-(2-aminoethyl)phenylboronic acid, 4-aminophenylboronic acid, 3-aminophenylboronic acid and double bond modified chondroitin sulfate, double bond modified hyaluronic acid, double bond modified gelatin, double bond modified sodium alginate, double bond modified polyglutamic acid, double bond modified carboxymethyl cellulose, double bond modified polymethacrylic acid; or is obtained by amidation or esterification reaction of any one of 3-carboxyphenylboronic acid, 4-carboxyphenylboronic acid, 4-(2-carboxyethyl)phenylboronic acid and double bond modified chitosan, double bond modified gelatin, double bond modified polyethylene glycol, double bond modified polyacrylamide.

[0012] Specifically, the silane coupling agent in step S1 is an aminosilane coupling agent, which is composed of at least one of γ-aminopropyltriethoxysilane, γ-aminoethylaminopropyltrimethoxysilane, γ-aminopropyltrimethoxysilane, and N-(β-aminoethyl-γ-aminopropyl)methyldimethoxysilane.

[0013] Specifically, the carboxyl-containing phenylboronic acid molecules in step S2 are a combination of at least one of 3-carboxylphenylboronic acid, 4-carboxylphenylboronic acid, and 4-(2-carboxyethyl)phenylboronic acid.

[0014] Specifically, the carboxyl-containing N,N-bis(2-hydroxyethyl) molecule in step S2 is a combination of at least one of N,N-bis(2-hydroxyethyl)aminoacetic acid, N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, and N,N-bis(2-hydroxyethyl)-4-aminobutyric acid.

[0015] Specifically, the aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymer or the aqueous solution containing double bonds and phenylboronic acid modified polymer in step S2 contains a photoinitiator, and the content of the photoinitiator is 0.01-10wt% by mass.

[0016] Specifically, the components of the bioceramic body include at least one combination of hydroxyapatite, β-tricalcium phosphate, trimagnesium phosphate, zirconium oxide, aluminum oxide, white calcium phosphate, tetracalcium phosphate, and octacalcium phosphate. The bioceramic body is formed by at least one of extrusion 3D printing, light-curing 3D printing, injection molding, and compression molding, and then sintered.

[0017] Preferably, by adding 3 wt % of loaded drugs to the aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers in step S3, a bioceramic loaded with drugs and coated with a bioactive coating on the surface can be obtained.

[0018] Another technical solution of the present invention to solve the above technical problems is:

[0019] A bioceramic surface bioactive coating is prepared by the above-mentioned preparation method.

[0020] The present invention has the following beneficial effects: a silane coupling agent is used on the surface of a bioceramic to react with the hydroxyl group on the surface of the ceramic through a hydrolysis reaction, thereby forming a stable bond at the inorganic-organic interface to form an active amino site, thereby solving the problem of lack of highly active groups on the surface of sintered bioceramics. Then, a phenylboronic acid molecule containing a carboxyl group or an N,N-bis(2-hydroxyethyl) molecule containing a carboxyl group is grafted onto the surface of the amino-modified bioceramic through an amidation reaction. Finally, by simply following the principle that phenylboronic acid corresponds to N,N-bis(2-hydroxyethyl) to select a corresponding double-bond modified polymer molecule, a bioactive coating that can be stably present can be constructed through a method of boron-nitrogen coordination combined with photocuring cross-linking, with flexible methods, stable process flow, and high success rate. The bioactive coating constructed by the present invention is based on a boron-nitrogen coordination compound with good bioactivity and multi-condition (acidic, alkaline, active oxygen, glucose) responsiveness, and can flexibly respond to complex in vivo microenvironments. It is suitable for responsive drug release in microenvironments such as inflammation, tumors and diabetes. At the same time, the double-bond cross-linking enhancement method is used to solve the problems of poor biostability and rapid degradation of boron-nitrogen coordination compounds, so that the invented bioactive coating has long-term biostability, microenvironment responsiveness and the ability to release multiple drugs in a long-term sustained manner.

[0021] The method of the present invention has a clear principle, a simple operation method, is easy to implement large-scale production, and can be adapted to most of the current bioceramic materials. In addition, the current 3D printing / additive manufacturing of bioceramics has broad prospects, and the market share and popularity are gradually increasing. Traditional surface modification methods such as vapor deposition and spraying cannot penetrate and cover all structural surfaces. The present invention is not limited by the material morphology and structure, and can be flexibly loaded on the surface of bioceramics with complex structures with special designs or personalized customization, which has significant advantages. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 The SEM image of the bioceramic coated with the bioactive coating on the surface of the present invention.

[0023] Figure 2 The diagram is a diagram showing the sustained release effect of the drug loaded in the present invention at different temperatures.

[0024] Figure 3 The diagram is a diagram showing the sustained release effect of the drug loaded in the present invention at different pH values. DETAILED DESCRIPTION

[0025] The present invention is described in detail below with reference to the embodiments.

[0026] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 1 of the present invention comprises the following steps:

[0027] S0, take the double bond modified chitosan raw material and dissolve it in a 2M 4-(2-carboxyethyl)phenylboric acid aqueous solution to make the modified chitosan concentration 20wt%, catalytic reaction under EDC / NHS system for 24h, and dialyze for 72h, freeze-drying to obtain preliminary double bond and phenylboric acid modified chitosan; then use the preliminary double bond and phenylboric acid modified chitosan as raw material, repeat the above steps to obtain fully grafted modified double bond and phenylboric acid modified chitosan, which is the double bond and phenylboric acid modified polymer required for use in this embodiment. Specifically, the double bond and phenylboronic acid modified polymer is obtained by amidation reaction of any one of 4-(2-aminoethyl)phenylboronic acid, 4-aminophenylboronic acid, 3-aminophenylboronic acid and double bond modified chondroitin sulfate, double bond modified hyaluronic acid, double bond modified gelatin, double bond modified sodium alginate, double bond modified polyglutamic acid, double bond modified carboxymethyl cellulose, double bond modified polymethacrylic acid; or by amidation or esterification reaction of any one of 3-carboxyphenylboronic acid, 4-carboxyphenylboronic acid, 4-(2-carboxyethyl)phenylboronic acid and double bond modified chitosan, double bond modified gelatin, double bond modified polyethylene glycol, double bond modified polyacrylamide. More preferably, in order to improve the modified grafting rate, the single grafting reaction product can be purified and used as a raw material, and the grafting reaction steps are repeated to improve the grafting rate of the product.

[0028] S1, the alumina bioceramic body prepared by the 3D printing method is suspended in a reaction vessel and immersed in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of γ-aminopropyltriethoxysilane with a mass fraction of 20wt%, reacted at room temperature for 24h, and washed to obtain an amino-modified bioceramic; preferably, the bioceramic body is formed by at least one of extrusion 3D printing, light-curing 3D printing, grouting molding, and compression molding, and then sintered. Preferably, the silane coupling agent is an aminosilane coupling agent, which is composed of at least one of γ-aminopropyltriethoxysilane, γ-aminoethylaminopropyltrimethoxysilane, γ-aminopropyltrimethoxysilane, and N-(β-aminoethyl-γ-aminopropyl)methyldimethoxysilane. Because the surface of the bioceramic after sintering lacks reactive groups for reaction, the purpose of selecting the above-mentioned silane coupling agent is to activate the surface of the bioceramic and introduce reactive amino groups.

[0029] S2, immersing the amino-modified bioceramic in a solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups. In this embodiment, the solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups is a methanol solution of N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, and the solute of the solution is 30wt% by mass. Subsequently, a catalytic reaction is carried out under an EDC / DMAP system for 24 hours, and the N,N-bis(2-hydroxyethyl) modified bioceramic is obtained after washing. The bioactive coating designed by the present invention is formed based on the coordination of N,N-bis(2-hydroxyethyl) and phenylboronic acid combined with double bond photocuring and cross-linking. It only needs to ensure that the ceramic surface active group and the subsequent double bond modified polymer contain N,N-bis(2-hydroxyethyl) groups and phenylboronic acid groups respectively.

[0030] S3, immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing a double bond and phenylboronic acid modified polymer, wherein the components in the aqueous solution in this embodiment include 30wt% of double bond and phenylboronic acid modified chitosan and 3wt% of photoinitiator by mass, and performing an oscillation reaction for 4h to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a 600s photopolymerization reaction on the boron-nitrogen internal coordination coating to initiate double bond polymerization to obtain a bioceramic coated with a bioactive coating on the surface, and its SEM image is as shown in FIG. Figure 1 shown.

[0031] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0032] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 2 of the present invention comprises the following steps:

[0033] S0, take the double bond modified carboxymethyl cellulose raw material and dissolve it in 1M N, N-bis (2-hydroxyethyl) -1, 3-diaminopropane aqueous solution to make the concentration of modified carboxymethyl cellulose 10wt%, catalytic reaction under EDC / NHS system for 24h, dialyzed for 72h, and freeze-dried to obtain preliminary double bonds and N, N-bis (2-hydroxyethyl) modified carboxymethyl cellulose; then use the preliminary double bonds and N, N-bis (2-hydroxyethyl) modified carboxymethyl cellulose as raw materials, repeat the above steps to obtain fully grafted modified double bonds and N, N-bis (2-hydroxyethyl) modified carboxymethyl cellulose.

[0034] S1, suspending the alumina bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of γ-aminoethylaminopropyltrimethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0035] S2, immersing the amino-modified bioceramic in a solution of phenylboronic acid molecules containing carboxyl groups, wherein the solution of phenylboronic acid molecules containing carboxyl groups in this embodiment is a methanol solution of 3-carboxylphenylboric acid, and the solute of the solution is 20 wt % by mass, and then performing a catalytic reaction under an EDC / DMAP system for 24 hours to obtain a phenylboric acid-modified bioceramic;

[0036] S3, immersing the phenylboric acid modified bioceramic in an aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers, wherein the components in the aqueous solution in this embodiment include 35wt% of double bonds and N,N-bis(2-hydroxyethyl) modified carboxymethyl cellulose and 2wt% of photoinitiator by mass, and performing an oscillation reaction for 2h to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a photopolymerization reaction of the boron-nitrogen internal coordination coating for 450s to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0037] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0038] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 3 of the present invention comprises the following steps:

[0039] S0, take the double bond modified gelatin raw material and dissolve it in a 2M 4-aminophenylboric acid aqueous solution to make the modified gelatin concentration 20wt%, catalyze the reaction under EDC / NHS system for 24h, dialyze for 72h, and freeze-dry to obtain preliminary double bond and 4-aminophenylboric acid modified gelatin; then use the preliminary double bond and 4-aminophenylboric acid modified gelatin as raw materials, repeat the above steps to obtain fully grafted modified double bond and 4-aminophenylboric acid modified gelatin, which is the double bond and phenylboric acid modified polymer required for use in this embodiment.

[0040] S1, suspending the hydroxyapatite bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of γ-aminopropyltrimethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0041] S2, immersing the amino-modified bioceramic in a solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups. In this embodiment, the solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups is a methanol solution of N,N-bis(2-hydroxyethyl) aminoacetic acid, and the solute of the solution is 15wt% by mass. Then, a catalytic reaction is carried out under an EDC / DMAP system for 24 hours, and the N,N-bis(2-hydroxyethyl) modified bioceramic is obtained after washing.

[0042] S3, immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing a double bond and phenylboronic acid modified polymer, wherein the components in the aqueous solution in this embodiment include 20wt% of double bonds and 4-aminophenylboronic acid modified gelatin and 1.5wt% of photoinitiator by mass, and performing an oscillation reaction for 3 hours to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a photopolymerization reaction on the boron-nitrogen internal coordination coating for 300 seconds to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0043] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0044] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 4 of the present invention comprises the following steps:

[0045] S0, take the double bond modified hyaluronic acid raw material and dissolve it in 1M N,N-bis(2-hydroxyethyl)-p-phenylenediamine aqueous solution to make the concentration of the modified hyaluronic acid be 10wt%, catalyze the reaction under EDC / NHS system for 24h, dialyze for 72h, and freeze-dry to obtain preliminary double bond and N,N-bis(2-hydroxyethyl)-p-phenylenediamine modified hyaluronic acid; then use the preliminary double bond and N,N-bis(2-hydroxyethyl)-p-phenylenediamine modified hyaluronic acid as raw materials, repeat the above steps to obtain fully grafted modified double bond and N,N-bis(2-hydroxyethyl)-p-phenylenediamine modified hyaluronic acid.

[0046] S1, suspending the hydroxyapatite bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of γ-aminopropyltrimethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0047] S2, immersing the amino-modified bioceramic in a solution of phenylboronic acid molecules containing carboxyl groups, wherein the solution of phenylboronic acid molecules containing carboxyl groups in this embodiment is a methanol solution of 4-(2-carboxyethyl)phenylboric acid, and the solute of the solution is 10 wt % by mass, and then performing a catalytic reaction under an EDC / DMAP system for 24 hours to obtain a phenylboric acid-modified bioceramic;

[0048] S3, immersing the phenylboric acid modified bioceramic in an aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers, wherein the components in the aqueous solution in this embodiment include 35wt% of double bonds and N,N-bis(2-hydroxyethyl) p-phenylenediamine modified hyaluronic acid and 1wt% of photoinitiator by mass, and performing an oscillation reaction for 3 hours to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a 500s photopolymerization reaction on the boron-nitrogen internal coordination coating to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0049] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0050] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 5 of the present invention comprises the following steps:

[0051] S0, take the double bond modified sodium alginate raw material and dissolve it in a 2M 3-aminophenylboric acid aqueous solution to make the concentration of the modified sodium alginate 20wt%, catalytic reaction under EDC / NHS system for 24h, dialyzed for 72h, and freeze-dried to obtain preliminary double bond and 3-aminophenylboric acid modified sodium alginate; then use the preliminary double bond and 3-aminophenylboric acid modified sodium alginate as raw material, repeat the above steps to obtain fully grafted modified double bond and 3-aminophenylboric acid modified sodium alginate, which is the double bond and phenylboric acid modified polymer required for use in this embodiment.

[0052] S1, suspending the β-tricalcium phosphate bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of N-(β-aminoethyl-γ-aminopropyl)methyldimethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0053] S2, immersing the amino-modified bioceramic in a solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups. In this embodiment, the solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups is a methanol solution of N,N-bis(2-hydroxyethyl)-4-aminobutyric acid, and the solute of the solution is 20wt% by mass. Then, a catalytic reaction is carried out under an EDC / DMAP system for 24 hours, and the N,N-bis(2-hydroxyethyl) modified bioceramic is obtained after washing.

[0054] S3, immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing a double bond and phenylboronic acid modified polymer, wherein the components in the aqueous solution in this embodiment include 10wt% by mass of double bonds and 3-aminophenylboronic acid modified sodium alginate and 0.5wt% by mass of a photoinitiator, and performing an oscillation reaction for 2 hours to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a 600s photopolymerization reaction on the boron-nitrogen internal coordination coating to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0055] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0056] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 6 of the present invention comprises the following steps:

[0057] S0, the double bond modified gelatin raw material is dissolved in a 2M N,N-bis(2-hydroxyethyl)aminoacetic acid aqueous solution to make the concentration of the modified gelatin raw material 20wt%, and the reaction is catalyzed for 24h under EDC / NHS system, and dialyzed for 72h, and freeze-dried to obtain preliminary double bonds and N,N-bis(2-hydroxyethyl)aminoacetic acid modified gelatin; then, the preliminary double bonds and N,N-bis(2-hydroxyethyl)aminoacetic acid modified gelatin are used as raw materials, and the above steps are repeated to obtain fully grafted modified double bonds and N,N-bis(2-hydroxyethyl)aminoacetic acid modified gelatin.

[0058] S1, suspending the β-tricalcium phosphate bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of N-(β-aminoethyl-γ-aminopropyl)methyldimethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0059] S2, immersing the amino-modified bioceramic in a solution of phenylboronic acid molecules containing carboxyl groups, wherein the solution of phenylboronic acid molecules containing carboxyl groups in this embodiment is a methanol solution of 4-carboxylphenylboric acid, and the solute of the solution is 20 wt % by mass, and then performing a catalytic reaction under an EDC / DMAP system for 24 hours to obtain a phenylboric acid-modified bioceramic;

[0060] S3, immersing the phenylboric acid modified bioceramic in an aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers, wherein the components in the aqueous solution in this embodiment include 30wt% of double bonds and N,N-bis(2-hydroxyethyl) aminoacetic acid modified gelatin and 1wt% of photoinitiator by mass, and performing an oscillation reaction for 1 hour to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a photopolymerization reaction on the boron-nitrogen internal coordination coating for 300 seconds to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0061] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0062] A method for preparing a bioactive coating on a bioceramic surface according to embodiment 7 of the present invention comprises the following steps:

[0063] S0, take the double bond modified hyaluronic acid raw material and dissolve it in 1M 4-(2-carboxyethyl)phenylboric acid aqueous solution to make the concentration of modified hyaluronic acid 10wt%, catalytic reaction under EDC / NHS system for 24h, dialyzed for 72h, and freeze-dried to obtain preliminary double bond and 4-(2-carboxyethyl)phenylboric acid modified hyaluronic acid; then the hyaluronic acid is modified with preliminary double bond and 4-(2-carboxyethyl)phenylboric acid, and the above steps are repeated to obtain fully grafted modified double bond and phenylboric acid modified chitosan, which is the double bond and 4-(2-carboxyethyl)phenylboric acid modified hyaluronic acid required for use in this embodiment.

[0064] S1, suspending the alumina bioceramic body prepared by the 3D printing method in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction. In this embodiment, the silane coupling agent solution is an ethanol solution of γ-aminopropyltriethoxysilane with a mass fraction of 20wt%, reacting at room temperature for 24h, and obtaining an amino-modified bioceramic after washing;

[0065] S2, immersing the amino-modified bioceramic in a solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups. In this embodiment, the solution of N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups is a methanol solution of N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, and the solute of the solution is 15wt% by mass. Then, a catalytic reaction is carried out under an EDC / DMAP system for 24 hours, and the N,N-bis(2-hydroxyethyl) modified bioceramic is obtained after washing.

[0066] S3, immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing a double bond and a phenylboronic acid modified polymer, wherein the components in the aqueous solution in this embodiment include 10wt% by mass of double bonds and 4-(2-carboxyethyl)phenylboronic acid modified hyaluronic acid and 1wt% by mass of a photoinitiator, and performing an oscillation reaction for 4 hours to obtain a boron-nitrogen internal coordination coating; then taking out the sample and placing it in a centrifuge for centrifugation to remove the unreacted aqueous solution on the surface, and then performing a 400s photopolymerization reaction on the boron-nitrogen internal coordination coating to initiate double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

[0067] Preferably, by adding 3 wt % vancomycin into the aqueous solution in step S3 of this embodiment, a bioceramic loaded with vancomycin and coated with a bioactive coating on the surface can be directly prepared.

[0068] Since the bioactive coating will cause new tissue attachment and deposition after implantation in the body, the stability of the bioactive coating obtained in Examples 1 to 7 was tested by weight loss measurement method through in vitro simulation experiments to characterize the specific testing method of the invention as follows:

[0069] After the bioceramics coated with the bioactive coating on the surface obtained in Examples 1 to 7 are fully dried, the initial mass M0 of the bioactive coating is determined by thermal gravimetric analysis (TGA), and the bioceramics with the bioactive coating are shaken and immersed in simulated body fluid at 37°C for 3, 7, 14, and 21 days, and then fully dried and the remaining masses M3, M7, M14, and M21 are determined by TGA.

[0070] Stability (%) = 100*(M0-M days) / M0

[0071] The experimental results are shown in the following table:

[0072] 3 days 7 days 14 days 21 days Example 1 98.7±1.3 94.4±0.7 90.1±2.2 80.5±1.4 Example 2 97.3±2.1 94.0±1.3 87.3±2.0 79.2±2.2 Example 3 99.3±0.6 95.7±3.2 89.4±1.4 81.8±3.0 Example 4 96.4±3.5 93.2±2.7 84.3±1.7 75.2±3.3 Example 5 95.4±1.7 91.1±0.4 81.3±1.3 70.2±2.8 Example 6 98.6±2.0 95.4±2.8 90.7±3.4 85.3±2.6 Example 7 94.2±3.3 90.8±1.2 80.1±4.2 73.2±3.8

[0073] As can be seen from the above table, all coatings can ensure more than 90% stability in the first 7 days, and all coatings can still maintain more than 70% stability after 21 days. It can be considered that the bioactive coating prepared by the present invention has high stability.

[0074] In addition, in order to characterize the improvement of the bioceramic performance by the bioactive coating, considering that the main purpose of the bioceramic is to repair and fill bone defects, the bioceramics with the bioactive coating obtained in Examples 1 to 7 were co-cultured with mouse bone marrow mesenchymal stem cells (BMSCs), so that the BMSCs cells grew on the surface of the bioceramics, and the cell proliferation rate of the BMSCs was measured by the CCK8 method at 1, 3, and 5 days. The specific method is as follows:

[0075] The bioceramics without the construction of the surface active layer were used as the control group, and their cell survival rates at 1, 3, and 5 days were n0-1, n0-3, and n0-5, while the survival rates at 1, 3, and 5 days in Example 1 were recorded as n1, n2, and n3.

[0076] Cell proliferation rate (%) = 100*n days / n0-days

[0077] The experimental results are shown in the following table:

[0078] 1 day 3 days 5 days Example 1 135.7±8.2 140.6±7.7 131.1±9.1 Example 2 121.8±5.3 124.9±5.9 133.3±7.8 Example 3 143.3±11.6 158.7±9.2 147.2±9.3 Example 4 187.4±7.7 193.2±12.8 179.4±17.3 Example 5 161.6±17.4 160.7±12.0 149.3±9.4 Example 6 158.3±12.1 135.4±18.7 145.8±13.6 Example 7 174.5±8.4 180.7±9.2 189.3±14.3

[0079] It can be seen from the above table that the cell proliferation rates of all examples on days 1, 3, and 5 are much greater than those of the blank control group, which indicates that the bioactive coating prepared by the present invention can significantly enhance the bioactivity of bioceramics.

[0080] Finally, in order to reflect the drug loading capability of the present invention, the water-soluble drug vancomycin is selected as a model drug, and the drug loading process is reflected in Examples 1 to 7. It must be pointed out that the model drug selected here is only to reflect the functionality of the invented bioactive coating, and does not play a role in limiting the performance of the invented coating. Other functions belonging to the present invention other than this embodiment should still fall within the scope of protection of this patent.

[0081] The biological activity based on boron-nitrogen coordination and double bond cross-linking designed according to the present invention should have responsiveness to pH, temperature, glucose, etc. Here, taking Examples 3 and 5 as examples, the sustained release of the inventive layer to drugs and the microenvironment responsiveness are studied respectively.

[0082] 1) Temperature responsiveness

[0083] The hydroxyapatite bioceramic with bioactive coating loaded with vancomycin prepared in Example 3 was subjected to a simulated model drug release experiment in PBS buffer solution, and the release concentration of vancomycin was recorded by ultraviolet spectrophotometry. Two groups of experiments were set up, one at room temperature 25°C and the other at 37.5°C. The drug sustained release curves were recorded for 1, 3, 7, and 14 days. Figure 2 shown.

[0084] 2) pH responsiveness

[0085] The β-tricalcium phosphate bioceramic with a bioactive coating loaded with vancomycin prepared in Example 5 was subjected to a simulated model drug release experiment in deionized water, and the release concentration of vancomycin was recorded using ultraviolet spectrophotometry. Two groups of experiments were set up, one group with a neutral pH and the other with a pH of 2, and the drug sustained release curves for 1, 3, 7, and 14 days were recorded. Figure 3 shown.

[0086] The experimental results all showed significant microenvironmental responsiveness and were able to maintain long-term drug retention and sustained release capabilities, indicating that the design strategy of the present invention effectively retains the multi-conditional responsiveness of the boron-nitrogen coordination compound.

[0087] The above contents are further detailed descriptions of the present invention in combination with specific preferred embodiments, and it cannot be determined that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as falling within the scope of protection of the present invention.

Claims

1. A method for preparing a bioactive coating on a bioceramic surface, characterized in that: The steps include: S1, suspending the prepared bioceramic body in a reaction container and immersing it in a silane coupling agent solution for surface grafting reaction, reacting at room temperature for 0.25 to 24 hours, and obtaining an amino-modified bioceramic; S2, immersing the amino-modified bioceramic in a solution of phenylboronic acid molecules containing carboxyl groups or N,N-bis(2-hydroxyethyl) molecules containing carboxyl groups, wherein the solute content of the solution is 1-50wt% by mass, and then performing a catalytic reaction under an EDC / DMAP system for 0.25-24h to obtain phenylboronic acid-modified bioceramic or N,N-bis(2-hydroxyethyl)-modified bioceramic; S3, immersing the phenylboric acid modified bioceramic in an aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers or immersing the N,N-bis(2-hydroxyethyl) modified bioceramic in an aqueous solution containing double bonds and phenylboric acid modified polymers, wherein the solute content of the solution is 1-50wt% by mass, and performing an oscillation reaction for 0.25-24h to obtain a boron-nitrogen internal coordination coating, and then after centrifugation, the boron-nitrogen internal coordination coating is subjected to a photopolymerization reaction for 10-1200s to induce double bond polymerization to obtain a bioceramic with a surface coated with a bioactive coating.

2. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: The double bond and N,N-bis(2-hydroxyethyl) modified polymer in step S3 are obtained by amidation reaction of any one of N,N-bis(2-hydroxyethyl)ethylenediamine, N,N-bis(2-hydroxyethyl)-1,3-diaminopropane, N,N-bis(2-hydroxyethyl)-p-phenylenediamine with any one of double bond modified chondroitin sulfate, double bond modified hyaluronic acid, double bond modified gelatin, double bond modified sodium alginate, double bond modified polyglutamic acid, double bond modified carboxymethyl cellulose, double bond modified polymethacrylic acid; or are obtained by amidation or esterification reaction of any one of N,N-bis(2-hydroxyethyl)aminoacetic acid, N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, N,N-bis(2-hydroxyethyl)-4-aminobutyric acid with any one of double bond modified chitosan, double bond modified gelatin, double bond modified polyethylene glycol, double bond modified polyacrylamide.

3. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: The double bond and phenylboronic acid modified polymer in step S3 is obtained by amidation reaction of any one of 4-(2-aminoethyl)phenylboronic acid, 4-aminophenylboronic acid, 3-aminophenylboronic acid and double bond modified chondroitin sulfate, double bond modified hyaluronic acid, double bond modified gelatin, double bond modified sodium alginate, double bond modified polyglutamic acid, double bond modified carboxymethyl cellulose, double bond modified polymethacrylic acid; or obtained by amidation or esterification reaction of any one of 3-carboxyphenylboronic acid, 4-carboxyphenylboronic acid, 4-(2-carboxyethyl)phenylboronic acid and double bond modified chitosan, double bond modified gelatin, double bond modified polyethylene glycol, double bond modified polyacrylamide.

4. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: The silane coupling agent in step S1 is an aminosilane coupling agent, which is composed of one or more of γ-aminopropyltriethoxysilane, γ-aminoethylaminopropyltrimethoxysilane, γ-aminopropyltrimethoxysilane, and N-(β-aminoethyl-γ-aminopropyl)methyldimethoxysilane.

5. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: The phenylboronic acid molecules containing carboxyl groups in step S2 are one or a combination of 3-carboxylphenylboronic acid, 4-carboxylphenylboronic acid, and 4-(2-carboxyethyl)phenylboronic acid.

6. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: The carboxyl-containing N,N-bis(2-hydroxyethyl) molecule in step S2 is one or a combination of N,N-bis(2-hydroxyethyl)aminoacetic acid, N,N-bis(2-hydroxyethyl)-3-aminopropionic acid, and N,N-bis(2-hydroxyethyl)-4-aminobutyric acid.

7. The method for preparing a bioactive coating on a bioceramic surface according to claim 1, characterized in that: In step S2, the aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymer or the aqueous solution containing double bonds and phenylboronic acid modified polymer both contain a photoinitiator, and the content of the photoinitiator is 0.01-10wt% by mass.

8. The method for preparing a bioactive coating on a bioceramic surface according to any one of claims 1 to 7, characterized in that: The components of the bioceramic body include one or more of hydroxyapatite, β-tricalcium phosphate, trimagnesium phosphate, zirconium oxide, aluminum oxide, white apatite, tetracalcium phosphate, and octacalcium phosphate. The bioceramic body is formed by one or more of the processes of extrusion 3D printing, light-curing 3D printing, injection molding, and compression molding, and then sintered.

9. The method for preparing a bioactive coating on a bioceramic surface according to any one of claims 1 to 7, characterized in that: By adding 3 wt % of loaded drugs to the aqueous solution containing double bonds and N,N-bis(2-hydroxyethyl) modified polymers in step S3, a bioceramic loaded with drugs and coated with a bioactive coating on the surface can be obtained.

10. A bioactive coating on a bioceramic surface, characterized in that: Prepared by the preparation method according to any one of claims 1 to 9.